Ernexa Therapeutics Inc. (ERNA) income statement
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.62−0.01 (-0.61%)
Close on Nov 18, 2026Market cap $2.64MP/E –Yield –
Ernexa Therapeutics Inc. financial ratios
See a number that looks wrong?